Enjoy complimentary customisation on priority with our Enterprise License!
The traumatic brain injury therapeutics market size will grow by $551.39 million during 2019-2023. The market's growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth.
This report provides a detailed analysis of the market by product (anticonvulsants, anti-anxiety agents, anticoagulants, analgesics, and other therapeutics) and geography (the Americas, APAC, and EMEA). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including Baxter, Fresenius, Johnson & Johnson Services, Novartis, and Pfizer.
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report
The large number of pipeline drugs and new drug approvals is the major factor driving the global traumatic brain injury therapeutics market growth. Due to the rising prevalence of traumatic brain injury (TBI), the number of drugs under development for its treatment is expanding at a significant rate. Most of the therapeutics that are in the last phases of development and expected to get marketing approval during the forecast period. Furthermore, there are a few drugs in the pipeline that demonstrate a decent efficacy and safety profile. Once these drugs are affirmed, they will expand the number of products in the market, and fuel the traumatic brain injury therapeutics market size growth.
The introduction of cell therapy and biologics is one of the major traumatic brain injury therapeutics market trends. There is no effective TBI treatment to improve neural structural repair and functional recovery of the patient. Many doctors believe cell therapy can be an effective treatment option due to its higher efficacy and target specificity. This is encouraging several companies to develop cell therapy as an independent treatment option for TBI. Some treatment options have already shown positive trial results and are expected to be launched soon. The traumatic brain injury therapeutics market forecast report predicts that fueled by these factors, the market will grow at a CAGR of almost 5% during the forecast period.
The traumatic brain injury therapeutics market is highly fragmented. The market is growing exponentially, offering development opportunities to several market players. The competitive landscape, therefore, is intense. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this traumatic brain injury therapeutics industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of various companies including:
Global traumatic brain injury therapeutics market analysis reveals the Americas will hold the largest traumatic brain injury therapeutics market share until 2023. The APAC region will account for the highest traumatic brain injury therapeutics market growth throughout the forecast period.
The anticonvulsants segment will lead the traumatic brain injury therapeutics market share during the forecast period. Anticonvulsants will also account for the highest traumatic brain injury therapeutics market growth. Additionally, the report also provides an accurate prediction of the contribution of the various products segments to the growth of the traumatic brain injury therapeutics market size.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
PART 12: VENDOR ANALYSIS
PART 13: APPENDIX
List of abbreviations
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.